[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.249.135. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
October 1987

The Antiviral Effects of Rose Bengal and Fluorescein

Author Affiliations

From The Eye and Ear Institute, The Eye and Ear Hospital, the Department of Ophthalmology, University of Pittsburgh.

Arch Ophthalmol. 1987;105(10):1415-1417. doi:10.1001/archopht.1987.01060100117039
Abstract

• We evaluated the antiviral effects of rose bengal and fluorescein sodium. The direct antiviral activity was determined by an in vitro direct neutralization assay. The 50% inhibitory dose was 16 μg/mL for rose bengal and 460 μg/mL for fluorescein. The in vivo antiviral effects of these drugs were determined in the mouse herpetic keratitis model. Following topical application, rose bengal reduced surface virus titers (swabs) 1 million-fold, and residual ocular virus (eye homogenates) 32-fold, compared with controls. No infectious virus was recovered by swabbing after topical application of rose bengal. Fluorescein had no significant effect on virus replication. Thus, rose bengal, unlike fluorescein, has significant antiviral activity, and the diagnostic use of rose bengal prior to viral culture may preclude a positive result. Also, the use of rose bengal to grade keratitis in the study of new antiviral agents should be discouraged.

References
1.
Norn MS:  Rose bengal vital staining . Acta Ophthalmol 1970;48:546-559.Article
2.
Passmore JW, King JH:  Vital staining of conjunctiva and cornea . Arch Ophthalmol 1955;53:568-574.Article
3.
Foster CS:  Corneal manifestations of neurologic diseases , in Smolin G, Thoft RA (eds): The Cornea . Boston, Little Brown & Co Inc, 1983, p 319.
4.
McGill J, Fraunfelder FT, Jones BR:  Current and proposed management of ocular herpes simplex . Surv Ophthalmol 1976;20:358-365.Article
5.
Marsh RJ, Fraunfelder FT, McGill JI:  Herpetic corneal epithelial disease . Arch Ophthalmol 1976;94:1899-1902.Article
6.
Stern AM, D'Aurora V, Sigman DS:  Inhibition of Escherichia coli DNA polymerase I by rose bengal . Arch Biochem Biophys 1980;202:525-532.Article
7.
Srivastava SK, Modak MJ:  Rose bengal mediated inhibition of DNA polymerases: Mechanism of inhibition of avian myeloblastosis virus reverse transcriptase under photo-oxidative conditions . Biochemistry 1983;22:2203-2288.Article
8.
Banks JG, Board RG, Carter J, et al:  Cytoxic and photodynamic inactivation of micro-organisms by rose bengal . J Appl Bacteriol 1985;58:391-400.Article
9.
Cruz FS, Lopes LAV, DeSouza W, et al:  The photodynamic action of rose bengal on Trypanosoma cruzi . Acta Trop 1984;41:99-108.
10.
Ray WA, O'Day DM, Head WS, et al:  Statistical analysis for experimental models of ocular disease: Continuous response measures . Curr Eye Res 1985;4:535-597.Article
11.
Jaanus SD:  Dyes , in Bartlett JD, Jaanus SD (eds): Clinical Ocular Pharmacology . Stoneham, Mass, Butterworth Publishers Inc, 1984, p 311.
12.
Jarrat M:  Photodynamic inactivation of herpes simplex virus . Photochem Photobiol 1972;25:339-340.Article
13.
Schnipper LE, Lewin AA, Swartz M, et al:  Mechanisms of photodynamic inactivation of herpes simplex virus . J Clin Invest 1980;65:432-438.Article
14.
Yen GSL, Simon EH:  Photosensitization of herpes simplex virus type I with neutral red . J Gen Virol 1978;41:273-281.Article
15.
Tara CS, Stanley JA, Kucera LS, et al:  Photodynamic inactivation of herpes simplex keratitis . Arch Ophthalmol 1974;92:51-53.Article
16.
Varneu ED, Kaufman HE:  Photodynamic inactivation with proflavine: Quantitating comparison with iodo-deoxyuridine . Infect Immun 1973;7:518-519.
17.
Moore C, Wallis C, Melnick JL, et al:  Photodynamic treatment of herpes keratitis . Infect Immun 1972;5:169-191.
18.
Felber TD, Smith EB, Knox JM, et al:  Photodynamic inactivation of herpes simplex: Report of a clinical trial . JAMA 1973;223:289-292.Article
19.
Bartholomew RS, Clarke M, Phillips CI:  'Dye/light': Dye-induced photosenitization of herpes virus: A clinical trial on humans . Trans Ophthalmol Soc UK 1977;97:508-509.
20.
O'Day DM, Jones BR, Poirer R, et al:  Proflavine photodynamic viral inactivation in herpes simplex keratitis . Am J Ophthalmol 1975;79:941-948.
21.
Berger RS, Papa CM:  Photodye herpes therapy: Cassadra confirmed? JAMA 1977;238:133-134.Article
22.
Li JLH, Jerkofsky MA, Rapp F:  Demonstration of oncogenic potential of mammalian cells transformed by DNA-containing viruses following photodynamic inactivation . Int J Cancer 1975;15:190-202.Article
23.
Rapp F, Li JLH, Jerkofsky M:  Transformation of mammalian cells by DNA-containing viruses following photodynamic inactivation . Virology 1973;55:339-346.Article
24.
Rapp F, Kemeny BA:  Oncogenic potential of herpes simplex virus in mammalian cells following photodynamic inactivation . Photochem Photobiol 1977;25:335-337.Article
25.
Gutter B, Speck WT, Rosenkranz HS:  Light-induced mutagenicity of neutral red (3-amino-7 dimethylamino-2-methylphenazine hydrochloride) . Cancer Res 1977;37:1112-1114.
26.
DeClercq E:  Comparative efficacy of antiherpes drugs in different cell lines . Antimicrob Agents Chemother 1982;21:661-663.Article
27.
Jernigan HM, Fukui HN, Goosey JD, et al:  Photodynamic effects of rose bengal or riboflavin on carrier-mediated transport systems in rat lens . Exp Eye Res 1981;32:461-466.Article
28.
Mol JA, Docter R, Hennemann G, et al:  Modification of rat liver iodothyronine 5-deiodinase activity with diethylpyrocarbonate and rose bengal evidence for an active site histidine residue . Biochem Biophys Res Commun 1984;120:28-36.Article
29.
Gordon YJ, Capone A, Sheppard J, et al:  2′-nor-cGMP, a new cyclic phosphate derivative of 2′NDG inhibits HSV-1 replication in vitro and in the mouse keratitis model . Curr Eye Res 1987;6:247-253.Article
×